Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.3%

1 terminated out of 19 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

83% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (6)
P 1 (1)
P 2 (5)

Trial Status

Recruiting6
Completed5
Unknown3
Not Yet Recruiting3
Terminated1
Active Not Recruiting1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT06971848Not ApplicableNot Yet Recruiting

Evaluation of Skin Tests in Biotherapy Allergies

NCT07432347RecruitingPrimary

Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches

NCT06523608Recruiting

Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease

NCT06900478Phase 2Not Yet RecruitingPrimary

Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC

NCT06886763Active Not RecruitingPrimary

HCC Innervation Assessment

NCT03755739Phase 2RecruitingPrimary

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

NCT03356236RecruitingPrimary

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

NCT05794048Not ApplicableRecruitingPrimary

METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors

NCT06041490Phase 2Not Yet Recruiting

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

NCT06028724Recruiting

A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)

NCT05464706Not ApplicableCompletedPrimary

Study on the Quality of Life (QoL) After Liver Surgery

NCT03956940Not ApplicableTerminatedPrimary

Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib

NCT05311319Phase 2UnknownPrimary

HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection

NCT04811898Phase 1Completed

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment

NCT03382327Not ApplicableCompletedPrimary

Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas

NCT02519075CompletedPrimary

11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE

NCT04435977Phase 2UnknownPrimary

Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma

NCT03718078Not ApplicableUnknownPrimary

Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery

NCT01411579Completed

Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma

Showing all 19 trials

Research Network

Activity Timeline